4.1 Article

Management of Anaplastic and Recurrent Differentiated Thyroid Cancer Indications for Surgical Resection, Molecular Testing, and Systemic Therapy

Journal

NEUROIMAGING CLINICS OF NORTH AMERICA
Volume 31, Issue 3, Pages 359-366

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.nic.2021.04.005

Keywords

Kinase inhibitor; BRAF; MEK; RET; NTRK

Funding

  1. Eisai
  2. Exelixis
  3. Genentech
  4. Merck
  5. Kura

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available